HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sun Young Kim Selected Research

3- (2- (3- (morpholinomethyl)phenyl)thieno(3,2- b)pyridin- 7- ylamino)phenol

3/2012LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sun Young Kim Research Topics

Disease

107Neoplasms (Cancer)
10/2022 - 04/2005
61Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 02/2009
48Rectal Neoplasms (Rectal Cancer)
01/2021 - 03/2010
22Neoplasm Metastasis (Metastasis)
07/2022 - 02/2002
16Colonic Neoplasms (Colon Cancer)
11/2022 - 02/2009
11Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2005
10Inflammation (Inflammations)
01/2020 - 08/2010
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 01/2011
9Adenocarcinoma
01/2021 - 10/2005
6Infections
03/2022 - 10/2011
5Disease Progression
01/2022 - 11/2012
5Breast Neoplasms (Breast Cancer)
11/2018 - 01/2008
5Carcinoma (Carcinomatosis)
07/2017 - 06/2007
4Nausea
10/2022 - 02/2010
4Microsatellite Instability
01/2022 - 05/2017
4Type 2 Diabetes Mellitus (MODY)
04/2021 - 05/2007
4Hypoxia (Hypoxemia)
07/2015 - 07/2009
3Vomiting
10/2022 - 02/2010
3Fatigue
10/2022 - 07/2010
3Tuberculosis (Tuberculoses)
03/2022 - 02/2010
3Thrombocytopenia (Thrombopenia)
01/2021 - 10/2014
3Sepsis (Septicemia)
12/2020 - 01/2018
3Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 04/2006
3Guillain-Barre Syndrome
07/2018 - 03/2013
3Margins of Excision
04/2018 - 07/2010
3Pathologic Complete Response
03/2017 - 02/2009
3Carcinogenesis
10/2016 - 05/2014
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2016 - 01/2007
3Neutropenia
10/2014 - 05/2013
3Necrosis
04/2014 - 09/2009
2Diarrhea
10/2022 - 04/2014
2Diabetes Mellitus
04/2021 - 02/2013
2Colitis
10/2020 - 09/2017
2Non-alcoholic Fatty Liver Disease
11/2019 - 11/2015
2Glaucoma
11/2019 - 07/2012
2Melanoma (Melanoma, Malignant)
06/2019 - 01/2018
2Thrombosis (Thrombus)
08/2018 - 10/2011
2Peripheral Nervous System Diseases (PNS Diseases)
07/2018 - 01/2018
2Lung Neoplasms (Lung Cancer)
01/2018 - 04/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 10/2016
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 06/2016
2Cataract (Cataracts)
07/2017 - 02/2013

Drug/Important Bio-Agent (IBA)

21Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2022 - 06/2009
15Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2007
15Capecitabine (Xeloda)FDA Link
01/2021 - 02/2008
12Biomarkers (Surrogate Marker)IBA
10/2022 - 11/2013
12Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2007
11Pharmaceutical PreparationsIBA
06/2022 - 08/2010
11Cetuximab (Erbitux)FDA Link
01/2022 - 06/2009
9Biological ProductsIBA
01/2022 - 08/2011
8Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 12/2012
8Carcinoembryonic AntigenIBA
02/2016 - 07/2010
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2008
7Bevacizumab (Avastin)FDA Link
01/2021 - 07/2009
7Leucovorin (Folinic Acid)FDA Link
01/2021 - 04/2013
7ErbB Receptors (EGF Receptor)IBA
01/2018 - 06/2009
6Messenger RNA (mRNA)IBA
12/2019 - 09/2007
6Cisplatin (Platino)FDA LinkGeneric
01/2016 - 01/2007
5SteroidsIBA
03/2022 - 02/2013
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2012
5Tyrosine Kinase InhibitorsIBA
12/2019 - 03/2012
4Immunoglobulin G (IgG)IBA
01/2021 - 09/2007
4Therapeutic UsesIBA
12/2020 - 02/2015
4AntigensIBA
01/2018 - 02/2010
3Calcibiotic Root Canal SealerIBA
11/2022 - 11/2013
3Lactic Acid (Lactate)FDA LinkGeneric
10/2022 - 07/2016
3RNA (Ribonucleic Acid)IBA
01/2022 - 02/2017
3Trastuzumab (Herceptin)FDA Link
01/2019 - 01/2008
3Gefitinib (Iressa)FDA Link
11/2018 - 02/2014
3Phosphotransferases (Kinase)IBA
01/2018 - 08/2010
3Epithelial Cell Adhesion MoleculeIBA
07/2017 - 10/2014
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016 - 11/2010
3Capsules (Microcapsules)IBA
10/2013 - 09/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 09/2009
2Gonadal Steroid Hormones (Sex Hormones)IBA
01/2022 - 06/2021
2Estrogens (Estrogen)FDA Link
01/2022 - 05/2013
2CKD-497IBA
01/2021 - 07/2020
2AcidsIBA
12/2020 - 05/2014
2Dextran SulfateIBA
10/2020 - 09/2017
2Transcription Factors (Transcription Factor)IBA
01/2020 - 05/2014
2regorafenibIBA
12/2019 - 07/2019
2AntibodiesIBA
07/2018 - 04/2014
2MucinsIBA
05/2018 - 01/2012
2Panitumumab (Vectibix)FDA Link
01/2018 - 11/2016
2Sorafenib (BAY 43-9006)FDA Link
01/2018 - 10/2016
2AZD4547IBA
08/2017 - 05/2017
2Adenosine Triphosphate (ATP)IBA
03/2017 - 06/2013

Therapy/Procedure

42Drug Therapy (Chemotherapy)
05/2022 - 02/2009
41Therapeutics
11/2022 - 01/2003
40Chemoradiotherapy
01/2021 - 03/2010
10Radiotherapy
07/2022 - 06/2010
8Adjuvant Chemotherapy
01/2022 - 07/2010
6Neoadjuvant Therapy
01/2021 - 07/2010
4Palliative Care (Palliative Therapy)
01/2022 - 07/2010
3Salvage Therapy
11/2017 - 11/2010
3Metastasectomy
06/2013 - 02/2009
2Radiofrequency Ablation
07/2022 - 07/2013
2Resuscitation
04/2020 - 01/2018
2Oral Administration
09/2017 - 01/2017
2Intraocular Lenses (Intraocular Lens)
07/2017 - 02/2013